+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Heparin"

From
From
From
Anticoagulants Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anticoagulants Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 144 Pages
  • Global
From
From
Heparin-Induced thrombocytopenia (HIT) - Pipeline Insight, 2024 - Product Thumbnail Image

Heparin-Induced thrombocytopenia (HIT) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Thrombocytopenia - Pipeline Insight, 2024 - Product Thumbnail Image

Thrombocytopenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Fondaparinux Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Fondaparinux Market Analysis & Forecast to 2024-2034

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Anticoagulants Market 2024-2028 - Product Thumbnail Image

Anticoagulants Market 2024-2028

  • Report
  • August 2024
  • 177 Pages
  • Global
From
From
From
From
Loading Indicator

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery. Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage. Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases. Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more